Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.

@article{Cigaina2003GastricPF,
  title={Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.},
  author={Valerio Cigaina and Angelica Lind{\'e}n Hirschberg},
  journal={Obesity research},
  year={2003},
  volume={11 12},
  pages={1456-62}
}
OBJECTIVE A gastric pacemaker has been developed to treat morbid obesity. Patients experience increased satiety, the ability to reduce food intake, and a resultant weight loss. However, the mechanism behind the changed eating behavior in paced patients is still under investigation. RESEARCH METHODS AND PROCEDURES This study was performed on 11 morbidly obese patients (mean BMI, 46.0 kg/m2) treated with gastric pacing. The peripheral blood levels of satiety signals of cholecystokinin (CCK… CONTINUE READING
25 Citations
31 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Effects of somatostatin on human satiety

  • RJ Lieverse, Jansen JBMJ, Masclee AAM, Lamers CBHW
  • Neuroen - docrinology
  • 1995
Highly Influential
4 Excerpts

Gastric pacing. A new operation technique in obese surgery

  • S Wolff, M Pross, C Knippig, P Malfertheiner, H. Lippert
  • Chirurg
  • 2002

Similar Papers

Loading similar papers…